|4Aug 8, 4:12 PM ET

Gemphire Therapeutics Inc. 4

4 · Gemphire Therapeutics Inc. · Filed Aug 8, 2016

Insider Transaction Report

Form 4
Period: 2016-08-04
Bisgaier Charles PhD
DirectorChair & Chief Scientific Off.10% Owner
Transactions
  • Award

    Employee Stock Option (right to buy)

    2016-08-04+150,000150,000 total
    Exercise: $10.00Exp: 2026-08-03Common Stock (150,000 underlying)
Footnotes (1)
  • [F1]The option vests in 48 equal consecutive monthly increments, so that all of the shares will be vested on the fourth anniversary of the date of grant.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT